Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
about
New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical TrialsTyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth FactorsProtective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.Protective effect of calycosin-7-O-β-D-glucopyranoside against oxidative stress of BRL-3A cells induced by thioacetamide.Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.Current frontiers in systemic sclerosis pathogenesis.A FGFR1 inhibitor patent review: progress since 2010.Sensitive, quantitative, and high-throughput detection of angiogenic markers using shape-coded hydrogel microparticles.Adverse outcome pathway development from protein alkylation to liver fibrosis.Emerging roles of FGF signaling in hepatocellular carcinoma.Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling.Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide.Cellular crosstalk during cholestatic liver injury
P2860
Q26772800-C53B4B02-3D19-4465-B00F-B4CDAE49A464Q28068710-C46667B0-D9C0-4485-8843-22476C6C74D1Q28076863-CF88A2E8-95B2-42E2-AE8D-F703482A1A86Q35767855-14280E61-D3ED-4530-986A-37FC2B319C05Q35910327-30F1F5FF-5870-45B5-B169-F715B51474B0Q36089694-74C5D972-44DC-414C-B441-F17CD4166E27Q38364957-93FC2FB7-9D1A-45AE-89B2-27116D935761Q38782612-9EFCDAD6-ADCE-4153-AF6B-5B5EA73D89E5Q38873232-589AF372-9124-48A9-AD40-AFBCA3773A9AQ38932043-DCE6D098-9479-45C7-83F1-3B14A07E6BA6Q41876265-1354381E-77EE-44DC-9825-F8F5CDF14658Q43190482-1BEEA782-1470-4934-9AAE-8DAE56DFDFE8Q47106480-0514FDF9-51A7-45F7-A308-0B7AC5716BCCQ57128724-A591AF2A-9D58-4EBD-B0B7-177F29B25722
P2860
Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Brivanib attenuates hepatic fi ...... FGF, VEGF and PDGF signaling.
@ast
Brivanib attenuates hepatic fi ...... FGF, VEGF and PDGF signaling.
@en
type
label
Brivanib attenuates hepatic fi ...... FGF, VEGF and PDGF signaling.
@ast
Brivanib attenuates hepatic fi ...... FGF, VEGF and PDGF signaling.
@en
prefLabel
Brivanib attenuates hepatic fi ...... FGF, VEGF and PDGF signaling.
@ast
Brivanib attenuates hepatic fi ...... FGF, VEGF and PDGF signaling.
@en
P2093
P2860
P1433
P1476
Brivanib attenuates hepatic fi ...... f FGF, VEGF and PDGF signaling
@en
P2093
Bubu A Banini
Catherine D Moser
Dalia S Mikhail
Hassan M Shaleh
Ian Walters
Ikuo Nakamura
Ju Dong Yang
Kais Zakharia
Sarah R Thornburgh
Tae Hyo Kim
P2860
P304
P356
10.1371/JOURNAL.PONE.0092273
P407
P577
2014-04-07T00:00:00Z